PRESS RELEASE published on 10/14/2024 at 19:45, 1 year 3 months ago Inventiva announces the availability of a prospectus in connection with its financing through the issuance of ordinary shares and pre-funded warrants Inventiva announces the availability of a prospectus for financing through the issuance of shares and warrants. The AMF approved the prospectus on October 14, 2024 Warrants Shares Financing Prospectus Inventiva
BRIEF published on 08/30/2024 at 11:04, 1 year 5 months ago UBS Group AG Crosses Threshold in INVENTIVA Capital AMF Threshold Crossing Transfer Of Shares Inventiva UBS Group AG
BRIEF published on 07/31/2024 at 22:05, 1 year 6 months ago Inventiva Reports Preliminary 2024 First-Half Financial Information Financial Results Revenue Inventiva H1 2024 R&D Expenses
PRESS RELEASE published on 07/31/2024 at 22:00, 1 year 6 months ago Inventiva Reports Preliminary 2024 First-Half Financial Information¹ Inventiva reports preliminary 2024 first-half financial information, including cash position, expenses, and funding concerns. No revenues recorded in H1 2024. Company remains focused on clinical trials and upcoming milestones Financial Information Cash Position Clinical Trials Inventiva Funding Concerns
BRIEF published on 07/25/2024 at 22:05, 1 year 6 months ago Inventiva Secures Patent in Japan for Lanifibranor Intellectual Property Japan Market Lanifibranor MASH/NASH Patent Approval
PRESS RELEASE published on 07/25/2024 at 22:00, 1 year 6 months ago Inventiva secures a new patent in Japan, expanding the IP protection of its lead product candidate lanifibranor Inventiva secures a new patent in Japan for lanifibranor, enhancing IP protection for cirrhosis treatment, including MASH/NASH indication Patent Japan Inventiva Lanifibranor Cirrhosis
BRIEF published on 07/23/2024 at 10:56, 1 year 6 months ago UBS Group exceeds the threshold of 5% of Inventiva's capital Voting Rights Acquisition Of Shares Crossing Threshold Inventive UBS Group
BRIEF published on 07/18/2024 at 08:35, 1 year 6 months ago Inventiva announces the issuance of royalty certificates for an amount of 20.1 million euros Biopharmaceutical Inventive Lanifibranor MASH/NASH Royalty Certificates
PRESS RELEASE published on 07/18/2024 at 08:30, 1 year 6 months ago Inventiva announces a €20.1 million issuance of royalty certificates Inventiva announces a €20.1 million issuance of royalty certificates to fund lanifibranor development, extending cash runway. Key shareholders involved in the transaction Strategic Options Inventiva Lanifibranor Royalty Certificates Cash Runway
BRIEF published on 07/05/2024 at 22:05, 1 year 7 months ago Inventiva: update on the NATiV3 clinical program and financial statement Funding Clinical Test Inventive NASH Lanifibranor
Published on 02/07/2026 at 01:00, 1 day 8 hours ago Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 10 hours ago Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 11 hours ago Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 18 hours ago Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 20 hours ago Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange
Published on 02/07/2026 at 21:00, 12 hours 51 minutes ago Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 17 hours 16 minutes ago The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 17 hours 31 minutes ago NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 14 hours ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 15 hours ago EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG
Published on 02/06/2026 at 18:22, 1 day 15 hours ago Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 17 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 18:06, 2 days 15 hours ago Aéroports de Paris SA - Shares and voting rights as of 31 January 2026